Role of Oxygen Free Radicals in Cancer Development

European Journal of Cancer

Volumn 32, Issue 1, 1996, Pages 30-38

  Dreher, D ^a   Junod, A F ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Antioxidants; Apoptosis; DNA repair; Mutagenesis; Oxidative stress; p53; Tumour promotion

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CATALASE; FREE RADICAL; OXYGEN RADICAL; SUPEROXIDE DISMUTASE;

APOPTOSIS; CARCINOGENESIS; DNA DAMAGE; MUTAGENESIS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TUMOR PROMOTION;

ANTIOXIDANTS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA REPAIR; FREE RADICALS; HUMANS; OXIDATIVE STRESS;

EID: 0029918901     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00531-5     Document Type: Review

References (115)

1. Janssen YMW, Van Houten B, Borm PJA, Mossman BT. Cell and tissue responses to oxidative damage. Lab Invest 1993, 69, 261-274.
2. Yu BP. Cellular defenses against damage from reactive oxygen species. Biol Rev 1994, 74, 139-162.
3. Davies KJ. Protein modification by oxidants and the role of proteolytic enzymes. Biochem Soc Transact 1993, 21, 346-353.
4. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993, 362, 709-715.
5. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med 1992, 119, 598-620.
6. Ames NB, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993, 90, 7915-7922.
7. Swartz HM. Electron spin resonance studies of carcinogenesis. In Advances in Cancer, Vol. 15. New York, Research Academic, 1972, 227-252.
8. Bielinski BH, Gebieki JM. Application of radiation chemistry to biology. In Free Radicals in Biology, Vol. 3. New York, Academic Press, 1977.
9. Weitzman SA, Stossel TP. Mutation caused by human phagocytes. Science 1981, 212, 546-547.
10. Mason RP, Chignell CF. Free radicals in pharmacology and toxicology. Pharmacol Rev 1982, 33, 189-211.
11. Nakayama T, Nagata C, Kodama M, Kaneko MK. Cigarette-smoke induced DNA single-strand breaks in human cells. Nature 1985, 314, 462-464.
12. Ames NB. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983, 221, 1256-1264.
13. Guyton KZ, Kensler TW. Oxidative mechanisms in carcinogenesis. Brit Med Bull 1993, 49, 523-544.
14. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994, 54, 1890s-1894s.
15. Cerutti PA. Oxy-radicals and cancer. Lancet 1994, 344, 862-863.
16. Klein G. The approaching era of tumor suppressor genes. Science 1987, 238, 1539-1545.
17. Hussain SP, Aguilar F, Amstad P, Cerutti P. Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene 1994, 9, 2277-2281.
18. Nakamura Y, Gindhart T, Winterstein D, Tomita I, Seed J, Colburn N. Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells. Carcinogenesis 1988, 9, 203-207.
19. Salim AS. The permissive role of oxygen-derived free radicals in the development of colonic cancer in the rat. A new theory for carcinogenesis. Int J Cancer 1993, 53, 1031-1035.
20. Freeman BA, Crapo JD. Biology of disease. Free radicals and tissue injury. Lab Invest 1982, 47, 421-426.
21. Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984, 219, 1-14.
22. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappaB transcription factor and HIV-1. EMBO J 1991, 10, 2247-2258.
23. Halliwell B, Aruoma OI. DNA damage by oxygen-derived species. Its mechanisms of action and measurements in mammalian system. FEBS Lett 1991, 281, 9-19.
24. Wink DA, Nimes RW, Saavedra JE, Utermahlen WE, Ford PC. The Fenton oxidation mechanism: reactivities of biologically relevant substrates with two oxidizing intermediates differ from those predicted for the hydroxyl radical. Proc Natl Acad Sci USA 1994, 91, 6604-6608.
25. Taniguchi N, Pickett CB, Griffith OW. Oxy radicals and antioxidative responses in cancer: 12th Sapporo Cancer Seminar Meeting Report. Cancer Res 1993, 53, 3207-3210.
26. Beckman JS, Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H. Peroxynitrite, a cloaked oxidant formed by nitric-oxide and superoxide. Chem Res Toxicol 1992, 5, 834-842.
27. Rubbo H, Radi R, Trujillo M, et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. J Biol Chem 1994, 269, 26 066-26 075.
28. Imlay JA, Linn S. DNA damage and oxygen radical toxicity. Science 1988, 240, 1302-1309.
29. Cerutti PA, Trump BF. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 1991, 3, 1-7.
30. Weiss SJ. Tissue distruction by neutrophils. N Engl J Med 1989, 320, 365-376.
31. Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990, 76, 655-663.
32. Collins RH, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 1987, 316, 1654-1658.
33. Mossman BT, Bignon J, Corn M, Seaton A, Gee JBL. Asbestos: scientific development and implications for public policy. Science 1990, 247, 294-301.
34. Rosin MP, Anwar WA, Ward A. Inflammation, chromosomal instability, and cancer: The Schistosomiasis model. Cancer Res 1994, 54, 1929s-1933s.
35. Arthur MJP, Hall AJ, Wright R. Hepatitis B, hepatocellular carcinoma, and strategies for prevention. Lancet 1984, 1, 607-610.
36. Shimoda R, Nagashima M, Sakamoto M, et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 1994, 54, 3171-3172.
37. Doll R, Peto R. The causes of cancer. Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981, 66, 1191-1308.
38. Stone K, Pryor WA. Cigarettes: then and now. J Lab Clin Med 1994, 124, 313-314.
39. Cosgrove JP, Church DF, Borish ET, Pryor WA. The metal-mediated formation of hydroxyl radicals by aqueous extract of cigarette tar. Biochem Biophys Res Comm 1985, 132, 390-396.
40. Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem J 1991, 277, 133-138.
41. Harris CC, Graftstrom R, Willey JC, et al. Pathobiological effects of tobacco smoke, tumor promotors, and asbestos in human lung cells in vitro. In Oxy-radicals in Molecular Biology and Pathology. New York, Alan R. Liss Inc., 1988.
42. Dix TA, Marnett LJ. Metabolism of polycyclic aromatic hydrocarbon derivatives to ultimate carcinogens during lipid peroxidation. Science 1983, 221, 77-79.
43. Frenkel K, Donahue JM, Banerjee S. Benzo(a)pyrene-induced oxidative DNA damage: a possible mechanism for promotion by complete carcinogens. In Oxy-radicals in Molecular Biology and Pathology. New York, Alan R. Liss Inc., 1988, 509-524.
44. Boon PJ, Cullis PM, Symons MCR, Wren BW. Effects of ionizing radiation on deoxyribonucleic acid and related systems. 1. The role of oxygen. J Chem Soc Perkin Trans 1984, II 8, 1393-1399.
45. Bruckdorfer KR. Lipids and cancer. Proc Roy Soc Med 1987, 80, 713-714.
46. Babbs CF. Free radicals and the etiology of colon cancer. Free Rad Biol Med 1990, 8, 191-200.
47. Nelson RL. Dietary iron and colorectal cancer risk. Free Radical Biol Med 1992, 12, 161-168.
48. Tkeshelashvili LK, McBride T, Spence K, Loeb, LA. Mutation spectrum of copper-induced DNA damage. J Biol Chem 1991, 266, 6401-6406.
49. Petrakis NL, Gruenke LD, Craig JC. Cholesterol and cholesterol epoxides in nipple aspirates of human breast fluid. Cancer Res 1981, 41, 2563-2565.
50. Mufti SI. Alcohol acts to promote incidence of tumors. Cancer Detect Prev 1992, 16, 157-162.
51. Demple B, Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem 1994, 63, 915-948.
52. Hsie A, Recio I, Katz D, Lee C, Wagner M, Schenley R. Evidence for reactive oxygen species inducing mutations in mammalian cells. Proc Natl Acad Sci USA 1986, 83, 9610-9620.
53. Moraes EC, Keyse SM, Tyrrell RM. Mutagenesis by hydrogen peroxide treatment of mammalian cells: a molecular basis. Carcinogenesis 1990, 11, 283-293.
54. von Sonntag C, Schuchmann HP. Radical-mediated DNA damage in the presence of oxygen. Meth Enzymol 1990, 186, 511-520.
55. Olinski R, Zastawny T, Budzbon J, Sokowski J, Zegarski W, Dizdarogly M. DNA base modifications in chromatin of human cancerous tissues. FEBS Lett 1992, 309, 193-198.
56. Jaruga P, Zastawny TH, Skokowski J, Dizdaroglu M, Olinski R. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett 1994, 341, 59-64.
57. Feig DI, Sowers LC, Loeb LA. Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA. Proc Natl Acad Sci USA 1994, 91, 6609-6613.
58. Aruoma OI, Dizdaroglu M, Halliwell B. Iron-dependent modification of bases in DNA by the superoxide radical-generating system hypoxanthine xanthine oxidase. J Biol Chem 1989, 264, 3024-3028.
59. Grollman AP, Moriya M. Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet 1993, 9, 246-249.
60. Bos J. The ras gene family and human carcinogenesis. Mutat Res 1988, 195, 255-271.
61. Takahashi T, Gazdar AF, Chiba I, et al. p53: a frequent target for genetic abnormalities in lung cancer. Science 1989, 246, 491-494.
62. Hsu I, Metcalf R, Sun T, Welsh J, Wang N, Harris C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991, 350, 427-428.
63. Cantoni O, Sestili P, Cattabeni F, et al. Calcium chelator Quin 2 prevents hydrogen-peroxide-induced DNA breakage and cytotoxicity. Eur J Biochem 1989, 2, 290-212.
64. 2+ in toxic cell killing. Trends Pharmac Sci 1989, 10, 281-285.
65. Remacle J, Lambert D, Raes M, Pigeolet E, Michiels C, Toussaint O. Importance of various antioxidant enzymes for cell stability. Confrontation between theoretical and experimental data. Biochem J 1992, 286, 41-46.
66. von Sonntag C. The Chemical Basis of Radiation Biology. London, Taylor and Francis, 1987.
67. Davies KJ, Sevanian A, Muakkassah-Kelli SF, Hochstein P. Uric acid-iron complexes: a new aspect of the antioxidant function of uric acid. Biochem J 1986, 235, 747-754.
68. Menkes MS, Cornstock GW, Vuileumier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum beta-carotene, vitamins A and E, selenium and the risk of lung cancer. N Engl J Med 1986, 315, 1250-1254.
69. Heinonen OP, Albanes D for the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994, 330, 1029-1035.
70. Marantz PR. Beta carotene, vitamin E, and lung cancer [Letter]. N Engl J Med 1994, 331, 661.
71. Greenberg ER, Baron JA, Stukel TA, et al. and the Skin Cancer Prevention Group. A clinical trial of beta-carotene to prevent basal-cell and squamous cell cancers of the skin. N Engl J Med 1990, 323, 789-795.
72. Greenberg ER, Baron JA, Tosteson TD, et al. for the Polyp Prevention Study Group. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994, 331, 141-147.
73. Ames NB, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981, 78, 6858-6862.
74. Winterbourn CC. Superoxide-dependent production of hydroxyl radicals in the presence of iron salts (Letter). Biochem J 1982, 205, 463.
75. Jacob RA, Keley DS, Pianalto FS, et al. Immunocompetence and oxidant defense during ascorbate depletion of healthy men. Am J Clin Nutr 1991, 54, 1302S-1309S.
76. Blot WJ, Li J-Y, Taylor PR, Li B. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993, 85, 1483-1492.
77. Wayner DDM, Burton GW, Ingold KU. The antioxidant efficiency of vitamin C is concentration-dependent. Biochim Biophys Acta 1986, 884, 119-123.
78. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 1976, 73, 3685-3689.
79. Satoh MS, Jones CJ, Wood RD, Lindahl, T. DNA excision-repair defect of xeroderma pigmentosum prevents removal of a class of oxygen free radical-induced base lesions. Proc Natl Acad Sci USA 1993, 90, 6335-6339.
80. Robbins HJ, Kraemer KH, Lutzner MA, Festoff BW, Coon HG. Xeroderma pigmentosum. An inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 1974, 80, 221-248.
81. Friedberg EC. DNA repair: looking back and peering forward. BioEssays 1994, 16, 645-649.
82. Culotta E, Koshland DE. DNA repair works its way to the top. Science 1994, 266, 1926-1929.
83. de Oliveira R, van der Kemp PA, Thomas D, Geiger A, Nehls P, Boiteux S. Formamidopyrimidine DNA glycosylase in the yeast Saccharomyces cerevisae. Nucleic Acids Res 1994, 22, 3760-3764.
84. McGoldrick JP, Yeh YC, Solomon M, Essigmann JM, Lu AL. Characterization of a mammalian homolog of the Escherischia coli MutY mismatch repair protein. Mol Cell Biol 1995, 15, 989-996.
85. Häring M, Rüdiger H, Demple B, Boiteux S, Epe B. Recognition of oxidized abasic sites by repair endonucleases. Nucleic Acids Res 1994, 22, 2010-2015.
86. Sancar A. Mechanisms of DNA excision repair. Science 1994, 266, 1954-1956.
87. Modrich P. Mismatch repair, genetic stability, and cancer. Science 1994, 266, 1959-1960.
88. Cleaver JE. It was a very good year for DNA repair. Cell 1994, 76, 1-4.
89. Realini CA, Althaus FR. Histone shuttling by polyADP-ribosylation. J Biol Chem 1992, 267, 18 858-18 865.
90. Ashwell JD, Berger NA, Cidlowski JA, Lane DP, Korsmeyer SJ. Coming to terms with death: apoptosis in cancer and immune development. Immunol Today 1994, 15, 147-151.
91. Cerutti PA. Prooxidant states and tumor promotion. Science 1985, 227, 375-381.
92. Crawford D, Amstad D, Foo Y, Cerutti P. Constitutive and phorbol-myristate acetate regulated antioxidant defense of mouse epidermal JB6 cells. Mol Carcinogenesis 1989, 2, 136-143.
93. Trush MA, Kensler TW. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Rad Biol Med 1991, 10, 211-216.
94. Dreher D, Junod AF. Differential effects of superoxide, hydrogen peroxide, and hydroxyl radical on intracellular calcium in human endothelial cells. J Cell Physiol 1995, 162, 147-153.
95. Crawford D, Zbinden I, Amstad P, Cerutti P. Oxidant stress induces the proto-oncogenes c-fos and m-myc in mouse epiderma cells. Oncogene 1988, 3, 27-32.
96. 2+]i in the induction of c-fos, c-jun, and c-myc mRNA in rat PTE after oxidative stress. FASEB J 1992, 6, 912-924.
97. 2+ and the regulation of early response gene expression in HL-60 myeloid leukemia cells. J Biol Chem 1993, 268, 16 596-16 601.
98. Larsson R, Cerutti P. Translocation and enhancement of phosphotransferase activity of protein kinase C following exposure in mouse epidermal cells to oxidants. Cancer Res 1989, 49, 5627-5632.
99. Larsson R, Cerutti P. Oxidants induce phosphorylation of ribosomal protein S6. J Biol Chem 1988, 263, 17 452-17 458.
100. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA 1989, 86, 6758-6762.
101. Storz G, Tartiglia LA, Ames BN. Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxidation. Science 1990, 248, 189-194.
102. Toledano MD, Leonard WJ. Modulation of transcription factor NF-kappaB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 1991, 88, 4328-4332.
103. Gilmore TD. Malignant transformation by mutant rel proteins. Trends Genet 1991, 7, 318-332.
104. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995, 358, 1-3.
105. Punnonen K, Asaishi K, HyotyM, Kudo R, Ahotupa M. Antioxidant enzyme activities and oxidative stress in human breast cancer. J Cancer Res Clin Oncol 1994, 120, 374-377.
106. Oren M. p53: the ultimate tumor suppressor gene? FASEB J 1992, 6, 3169-3176.
107. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992, 70, 523-526.
108. Kemp CJ, Wheldon T, Balmain A. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genetics 1994, 8, 66-69.
109. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994, 15, 7-10.
110. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992, 80, 879-886.
111. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993, 75, 241-251.
112. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Cancer Biol 1992, 4, 327-332.
113. Pierce JP, Thurmond L, Rosbrook B. Projecting international lung cancer mortality rates: first approximations with tobacco-consumption data. Monogr J Natl Cancer Inst 1992, 12, 45-49.
114. Maneval DC, Harris M, Tam K, et al. p53 tumor suppressor gene-therapy of cancer-preclinical studies. Abstr Am Chem Soc 1994, 207, 110.
115. Gregory RJ, Maneval DC, Sutjipto S, et al. Tumor-suppressor gene-therapy of cancer - adenoviral mediated gene-transfer of the p53 cDNA into human tumor cell lines. J Cell Biochem 1994, S18A, 237.